Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism S1PRs modulators(Sphingosine 1-phosphate receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Autobahn Therapeutics, Inc.Startup |
Active Organization Autobahn Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroinflammation | Preclinical | US | Autobahn Therapeutics, Inc.Startup | 11 Sep 2023 |